EUVIMEDEUVIMED entdecken
CrossrefInfokarte

No Significant Differences in Antidepressant Remission and Response Rates Between Anxious and Nonanxious Depression: A Multicenter Study in Taiwan

Wei-Yang Lee, Hsiao-Hui Tsou, Si-Yu Chu, Ya-Ting Hsu, Chia-Yih Liu, Chin-Fu Hsiao, Huang-Li Lin

Depression and Anxiety · 2026-01 · 2026 (1)

DOI: 10.1155/da/3138685 ↗
AbstractBibliografische Angaben

Abstract

Background Anxious depression, defined by coexisting anxiety and depressive symptoms, has been associated with poorer treatment outcomes, though findings remain inconsistent. This study examined whether anxious depression influences antidepressant efficacy in an Asian population. Methods This multicenter, single‐blind study across five hospitals was conducted in Taiwan from May 2006 to December 2009. Patients aged 18 and older with major depressive disorder (MDD) were diagnosed and treated with either escitalopram or paroxetine. The Hamilton Rating Scale for Depression (HAM‐D) and the Beck Depression Inventory‐II (BDI‐II) assessed outcomes. Anxious depression was defined as a HAM‐D anxiety factor score ≥ 7. We assessed treatment efficacy by remission and response rates, as well as changes in depression scores. Results The study included 302 patients, of whom 193 were classified as having anxious depression and 109 as having nonanxious depression. No significant differences were observed in treatment dosage or duration between the anxious and nonanxious depression groups. HAM‐D‐defined remission rates were 40.4% and 43.1%, respectively (adjusted OR = 0.9, 95% CI = 0.6–1.5, and p = 0.651), and response rates were 62.2% and 56.9% (adjusted OR = 1.2, 95% CI = 0.7–1.9, and p = 0.517). The anxious depression group showed a greater reduction in HAM‐D scores (−13.0 vs. −10.4; adjusted mean difference = −1.9, 95% CI = −3.5 to −0.4, and p = 0.014), whereas the percentage change did not differ significantly between groups (adjusted p = 0.529). BDI‐II outcomes likewise showed no significant between‐group differences. Time to remission (log‐rank p = 0.599) and response (log‐rank p = 0.264) also did not differ significantly. Conclusions In this Taiwanese multicenter outpatient cohort, anxious depression was not significantly associated with lower remission or response rates during 8 weeks of treatment with escitalopram or paroxetine. These findings contribute to the limited evidence on antidepressant outcomes among Asian outpatients with anxious depression. However, the absence of statistically significant differences should not be interpreted as evidence of equivalence, and further prospective studies with larger and better‐balanced samples are needed to confirm these findings. Trial Registration: ClinicalTrials.gov identifier: NCT00384020

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →